Sort
64,565 grants matching “drug discovery”
A New Class of Broad-Spectrum Antibacterial Agents to Treat Multi-Drug Resistant Pathogens
$1,000,000Paul Sebahar · Curza Inc · R44 · FY2024 · AI
NIRT: Hierarchical Bionanomanufacturing
$1,000,000Robert L Clark · Duke University · · FY2006 · ENG
Selective Decorporation Agents for NIAID
$1,000,000Benjamin P Warner · Icagen, Inc. · R44 · FY2012 · AI
Assigning mode of action to phenotypically discovered anticancer leads.
$1,000,000Sergei S Makarov · Attagene, Inc. · R44 · FY2024 · CA
Program 1: Therapeutic Development Program (TDP)
$1,000,000William R. Montfort · University Of Arizona · P30 · FY2021 · CA
Restoring Beta-lactam efficacy against methicillin-resistant Staphylococci
$1,000,000Terry Roemer · Prokaryotics, Inc. · R44 · FY2020 · AI
Novel Combination Product with Activity Against MRSA, MDR-Enterics and Pseudomonas
$1,000,000Christopher John Burns · Venatorx Pharmaceuticals, Inc. · R44 · FY2019 · AI
Investigational New Drug (IND)-enabling and Early-Stage Development of Selective, Reversible, Orally Bioavailable ALDH2 inhibitor ANS-00858 to Treat Alcohol Use Disorder.
$1,000,000Brent Keith Blackburn · Amygdala Neurosciences, Inc. · U43 · FY2023 · AA
Molecular Biomedical Imaging Laboratory
$1,000,000David Bluemke · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2010 · EB
Random Shear Shuttle BAC Libraries for Antimicrobial Discovery from Soil Metageno
$1,000,000David Alan Mead · Lucigen Corporation · R44 · FY2013 · AI
R-5280, A Novel Modified Superior Resistant Starch Therapy for Type 1 Diabetes
$1,000,000Christian Furlan Freguia · Rise Therapeutics, Llc · R44 · FY2023 · DK
A parallelized computational microscope platform for high-throughput live imaging of patient-derived organoids
$1,000,000Mark Harfouche · Ramona Optics, Inc. · R44 · FY2025 · CA
Development of the NephroPlate: A high-throughput kidney-on-a-chip platform for identifying chronic kidney disease therapies
$1,000,000Kristin M Bircsak · Mimetas Us, Inc. · R44 · FY2022 · DK
D-ISN: TRACK 1: A Holistic Approach to Discovery, Modeling, and Interdiction of Drug and Human Trafficking Networks in the U.S. Southwest
$1,000,000Dominique E Roe-Sepowitz · Arizona State University · · FY2021 · ENG
Collaborative Research: EPiQC: Enabling Practical-Scale Quantum Computation
$1,000,000Andrew A Houck · Princeton University · · FY2018 · CSE
FET Medium: Next-generation DNA-based Computing and Memory Materials
$1,000,000Mark Bathe · Massachusetts Institute Of Technology · · FY2024 · CSE
Program 1: Therapeutic Development Program (TDP)
$1,000,000William R. Montfort · University Of Arizona · P30 · FY2020 · CA
Rapid discovery of thousands of intact biosynthetic gene pathways for bioactive natural product compounds from un-sequenced filamentous fungi using a novel FAC-NGS tool
$1,000,000Chengcang Charles Wu · Intact Genomics, Inc. · R44 · FY2020 · AI
Restoring Beta-lactam efficacy against methicillin-resistant Staphylococci
$1,000,000Terry Roemer · Prokaryotics, Inc. · R44 · FY2019 · AI
Novel Combination Product with Activity Against MRSA, MDR-Enterics and Pseudomonas
$1,000,000Christopher John Burns · Venatorx Pharmaceuticals, Inc. · R44 · FY2020 · AI
Assigning mode of action to phenotypically discovered anticancer leads.
$1,000,000Sergei S Makarov · Attagene, Inc. · R44 · FY2023 · CA
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
$1,000,000Steven Joseph Darnell · Dnastar, Inc. · R44 · FY2023 · AI
Enabling Toxoplasma gondii Kinome Directed Drug Discovery
$1,000,000Reena Zutshi · Luceome Biotechnologies, Llc · R44 · FY2024 · AI
Augmenting the CMDKP with advanced features for understanding biological mechanisms
$999,999Jason Flannick · Broad Institute, Inc. · UM1 · FY2025 · DK
KL4 Surfactant to Mitigate Radiation-Induced Lung Injury
$999,999Robert Segal · Discovery Laboratories, Inc. · R44 · FY2014 · AI